Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0696 per EA under NDC 00093342705. Its NADAC has been published 254 times since Aug 18, 2021.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342705
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072928On Market Since
7/20/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 254 times since Aug 18, 2021, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0696 per EA |
|---|---|
| All-time high | $0.0866 (Jan 10, 2024) |
| All-time low | $0.0523 (Nov 20, 2024) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0706 |
| Average price | $0.0707 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 254 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0696 per EA (NDC 00093342705), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has declined 11.7%. It has been tracked across 254 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Aug 18, 2021, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0523 (Nov 20, 2024) to a high of $0.0866 (Jan 10, 2024), with a median of $0.0706 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 2 MG TABLET, is $0.0424 per EA — about 39% below LORAZEPAM 2 MG TABLET.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 00093342705) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification